322 related articles for article (PubMed ID: 27126562)
1. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes.
Kooi IE; Mol BM; Massink MP; Ameziane N; Meijers-Heijboer H; Dommering CJ; van Mil SE; de Vries Y; van der Hout AH; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
Sci Rep; 2016 Apr; 6():25264. PubMed ID: 27126562
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
5.
Price EA; Patel R; Scheimberg I; Kotiloglu Karaa E; Sagoo MS; Reddy MA; Onadim Z
Ophthalmic Genet; 2021 Oct; 42(5):604-611. PubMed ID: 34003079
[No Abstract] [Full Text] [Related]
6. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies.
Rushlow DE; Mol BM; Kennett JY; Yee S; Pajovic S; Thériault BL; Prigoda-Lee NL; Spencer C; Dimaras H; Corson TW; Pang R; Massey C; Godbout R; Jiang Z; Zacksenhaus E; Paton K; Moll AC; Houdayer C; Raizis A; Halliday W; Lam WL; Boutros PC; Lohmann D; Dorsman JC; Gallie BL
Lancet Oncol; 2013 Apr; 14(4):327-34. PubMed ID: 23498719
[TBL] [Abstract][Full Text] [Related]
8. Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression.
Kooi IE; Mol BM; Moll AC; van der Valk P; de Jong MC; de Graaf P; van Mil SE; Schouten-van Meeteren AY; Meijers-Heijboer H; Kaspers GL; Te Riele H; Cloos J; Dorsman JC
EBioMedicine; 2015 Jul; 2(7):660-70. PubMed ID: 26288838
[TBL] [Abstract][Full Text] [Related]
9. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Schieffer KM; Feldman AZ; Kautto EA; McGrath S; Miller AR; Hernandez-Gonzalez ME; LaHaye S; Miller KE; Koboldt DC; Brennan P; Kelly B; Wetzel A; Agarwal V; Shatara M; Conley S; Rodriguez DP; Abu-Arja R; Shaikhkhalil A; Snuderl M; Orr BA; Finlay JL; Osorio DS; Drapeau AI; Leonard JR; Pierson CR; White P; Magrini V; Mardis ER; Wilson RK; Cottrell CE; Boué DR
Acta Neuropathol Commun; 2021 Apr; 9(1):61. PubMed ID: 33827698
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
[TBL] [Abstract][Full Text] [Related]
12. A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.
Kooi IE; Mol BM; Massink MP; de Jong MC; de Graaf P; van der Valk P; Meijers-Heijboer H; Kaspers GJ; Moll AC; Te Riele H; Cloos J; Dorsman JC
PLoS One; 2016; 11(4):e0153323. PubMed ID: 27115612
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing in osteosarcoma reveals important heterogeneity of genetic alterations.
Bousquet M; Noirot C; Accadbled F; Sales de Gauzy J; Castex MP; Brousset P; Gomez-Brouchet A
Ann Oncol; 2016 Apr; 27(4):738-44. PubMed ID: 26787232
[TBL] [Abstract][Full Text] [Related]
14. RB1 gene inactivation by chromothripsis in human retinoblastoma.
McEvoy J; Nagahawatte P; Finkelstein D; Richards-Yutz J; Valentine M; Ma J; Mullighan C; Song G; Chen X; Wilson M; Brennan R; Pounds S; Becksfort J; Huether R; Lu C; Fulton RS; Fulton LL; Hong X; Dooling DJ; Ochoa K; Mardis ER; Wilson RK; Easton J; Zhang J; Downing JR; Ganguly A; Dyer MA
Oncotarget; 2014 Jan; 5(2):438-50. PubMed ID: 24509483
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.
Racher H; Soliman S; Argiropoulos B; Chan HS; Gallie BL; Perrier R; Matevski D; Rushlow D; Piovesan B; Shaikh F; MacDonald H; Corson TW
Cancer Genet; 2016; 209(7-8):359-63. PubMed ID: 27318443
[TBL] [Abstract][Full Text] [Related]
16. Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.
da Costa AABA; do Canto LM; Larsen SJ; Ribeiro ARG; Stecca CE; Petersen AH; Aagaard MM; de Brot L; Baumbach J; Baiocchi G; Achatz MI; Rogatto SR
BMC Cancer; 2019 May; 19(1):422. PubMed ID: 31060523
[TBL] [Abstract][Full Text] [Related]
17. A Rapid and Sensitive Next-Generation Sequencing Method to Detect RB1 Mutations Improves Care for Retinoblastoma Patients and Their Families.
Li WL; Buckley J; Sanchez-Lara PA; Maglinte DT; Viduetsky L; Tatarinova TV; Aparicio JG; Kim JW; Au M; Ostrow D; Lee TC; O'Gorman M; Judkins A; Cobrinik D; Triche TJ
J Mol Diagn; 2016 Jul; 18(4):480-93. PubMed ID: 27155049
[TBL] [Abstract][Full Text] [Related]
18. RB1 screening of retinoblastoma patients in Sri Lanka using targeted next generation sequencing (NGS) and gene ratio analysis copy enumeration PCR (GRACE-PCR).
Kugalingam N; De Silva D; Abeysekera H; Nanayakkara S; Tirimanne S; Ranaweera D; Suravajhala P; Chandrasekharan V
BMC Med Genomics; 2023 Nov; 16(1):279. PubMed ID: 37932687
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing of RB1gene for the molecular diagnosis of ethnic minority with retinoblastoma in Yunnan.
Zhang Z; Xiao YS; Shen R; Jiang HC; Tan L; Li RQ; Yang XH; Gu HY; He WJ; Ma J
BMC Med Genet; 2020 Nov; 21(1):230. PubMed ID: 33225895
[TBL] [Abstract][Full Text] [Related]
20. Variability in retinoblastoma genome stability is driven by age and not heritability.
Polski A; Xu L; Prabakar RK; Gai X; Kim JW; Shah R; Jubran R; Kuhn P; Cobrinik D; Hicks J; Berry JL
Genes Chromosomes Cancer; 2020 Oct; 59(10):584-590. PubMed ID: 32390242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]